This study attempts to improve TRUS-guided prostate biopsy by utilizing assistance from a novel robotic TRUS manipulator (TRUS-Robot) developed by our team. The hypothesis of the study is that clinically significant prostate cancer detection rate from the SB cores (at SB or TB+SB) can be improved above that of current devices. The objective of the study is to gain early evidence on the effectiveness of prostate biopsy assisted by the TRUS-Robot vs. a current TB device in a randomized clinical trial.
Age
45–75
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Scheduled for an initial diagnostic biopsy
Elevated serum PSA (prostate specific antigen\> 4 ng/ml) and/or abnormal digital rectal exam
You may not be if
Clinical diagnosis of prostate cancer
Prior prostate biopsy
Anal stenosis that prevents TRUS probe insertion
Inadequate bowel prep
Unwilling or unable to sign the informed consent
Clareo Health | Transrectal Ultrasound Robot-Assisted Prostate Biopsy
